You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 12月2日港股盤前

根據uSMART輿情監測數據,從1日晚間到2日港股盤前時間段,市場關注指數最高的3只股票是復星醫藥、新創建集團、匯豐控股。

12月2日—港股關注排行TOP3

輿情變化榜單

復星醫藥

個股K線圖

關注度第一爲復星醫藥,該股上個交易日收盤下跌5.23%,報於24.45港元。近5個交易日累計持平。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

復星醫藥:復雲健康擬向復星健康、寧波復技、復星高科技合共借款不超過6550萬元

復星醫藥:復宏漢霖擬爲漢霖製藥不超2億元融資提供擔保

新創建集團

個股K線圖

關注度第二爲新創建集團,該股上個交易日收盤下跌1.25%,報於6.33港元。近5個交易日累計上漲0.16%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

新創建集團擬5.557億元收購湖南道嶽高速公路實業60%權益

新創建集團擬5.557億元收購湖南道嶽高速公路實業餘下60%股權

匯豐控股

個股K線圖

關注度第三爲匯豐控股,該股上個交易日收盤上漲0.11%,報於47.30港元。近5個交易日累計上漲2.83%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

匯豐祈耀年:不相信平保分拆建議有政治動機

匯豐控股CEO:英國在預算危機後已恢復經濟信譽

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account